Clinical Trial Update: Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23mg [Phase 3]

View source ↗

Summary

Phase 3 trial updating the optimal dose escalation strategy to achieve high-dose donepezil 23 mg for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Donepezil 23 mg (donepezil)

Snippet

Sponsor: Asan Medical Center | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED